SABBY 13G XTLB 4.02.15

Company

XTL BIOPHARMACEUTICALS LTD

Filed

April 2, 2015

Accession Number

0001535610-15-000054

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →